TWST vs. NTRA: Which Genomics Play Is a Better Buy?

TWST vs. NTRA: Which Genomics Play Is a Better Buy?

Cathie Wood’s Ark funds have been really heating up in recent months. Perhaps her most intriguing and underrated fund is the Ark Genomics Revolution ETF (ARKG), which is packed full of extraordinary biotech innovators that could experience an AI tailwind like few other industries. Unlike the other Ark funds that have been experiencing S&P-topping returns so far this year, the ARKG has continued to drag its feet. While the ARKG has been a relativ…